BioSpace News Archive

Palatin Technologies, Inc. announced that Paul Kayne, Ph.D., Vice President of Biological Sciences at Palatin, presented at the Eyecelerator@AAO in Chicago, IL.

Trefoil Therapeutics announced positive Phase 2 results for TTHX1114 in patients with Fuchs Endothelial Corneal Dystrophy.

YishengBio Co., Ltd. and Summit Healthcare Acquisition Corp. announced that they have entered into a definitive agreement for a business combination of Summit and the Company.

ViCapsys Life Sciences, Inc., announced the appointment of Mr. Richard Rosenblum, Dr. Colleen Delaney, and Mr. Charles Farrahar to the Company’s Board of Directors, effective September 22, 2022.

Kezar Life Sciences, Inc. announced that three posters will be presented at the upcoming American College of Rheumatology Convergence 2022, which will take place November 10 – 14, 2022 in Philadelphia, PA.

Encompass Health Corp. announced it will report results for its third quarter ended Sept. 30, 2022, after the market closes on Oct. 26, 2022.

ENDRA Life Sciences Inc., a pioneer of imaging technologies and Thermo Acoustic Enhanced UltraSound, announces an update to its plan to submit a De Novo request for the TAEUS system to the U.S. Food and Drug Administration.

Illumina, Inc. announced multiple breakthrough sequencing innovations at its inaugural Illumina Genomics Forum.

Astellas Pharma Inc. announced the European Medicines Agency has accepted for regulatory review the company’s marketing authorization application for fezolinetant, an investigational oral, nonhormonal compound seeking approval for the treatment of moderate to severe vasomotor symptoms associated with menopause.

Vanda Pharmaceuticals Inc. and OliPass Corporation announced that they have entered into a research and development collaboration agreement to jointly develop a set of antisense oligonucleotide molecules based on OliPass’ proprietary modified peptide nucleic acids.